Telomere shortening is associated with stem cell decline, fibrotic disorders, and premature aging through mechanisms that are incompletely understood. Here, we show that telomere shortening in livers of telomerase knockout mice leads to a p53-dependent repression of all seven sirtuins. P53 regulates non-mitochondrial sirtuins (Sirt1, 2, 6, and 7) post-transcriptionally through microRNAs (miR-34a, 26a, and 145), while the mitochondrial sirtuins (Sirt3, 4, and 5) are regulated in a peroxisome proliferator-activated receptor gamma co-activator 1 alpha-/beta-dependent manner at the transcriptional level. Administration of the NAD(+) precursor nicotinamide mononucleotide maintains telomere length, dampens the DNA damage response and p53, improves mitochondrial function, and, functionally, rescues liver fibrosis in a partially Sirt1-dependent manner. These studies establish sirtuins as downstream targets of dysfunctional telomeres and suggest that increasing Sirt1 activity alone or in combination with other sirtuins stabilizes telomeres and mitigates telomere-dependent disorders.
Pubmed ID: 30930169 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Software tool as a pattern based algorithm for detecting microRNA binding sites and their corresponding microRNA and mRNA complexes. Allows interactive exploration and visualization of miRNA target predictions. Permits link-out to external expression repositories and databases.
View all literature mentionsThis polyclonal targets Vinculin
View all literature mentionsThis monoclonal targets Histone H2A.X, phospho (Ser139)
View all literature mentionsThis unknown targets GFP Antibody
View all literature mentionsThis polyclonal targets CPS1 - Liver Mitochondrial Marker
View all literature mentionsThis monoclonal targets VDAC1 / Porin
View all literature mentionsThis polyclonal targets Acetylated-Lysine
View all literature mentionsThis monoclonal targets Sod2
View all literature mentionsThis monoclonal targets Actin, α-Smooth Muscle
View all literature mentionsThis monoclonal targets FoxO1 (C29H4) Rabbit mAb
View all literature mentionsThis monoclonal targets PGC-1α
View all literature mentionsThis polyclonal targets PPARGC1A
View all literature mentionsThis unknown targets Recombinant mouse p53 protein
View all literature mentionsThis unknown targets Rabbit IgG (H+L)
View all literature mentionsThis polyclonal targets H4K16ac
View all literature mentionsThis unknown targets Mouse IgG (H+L)
View all literature mentionsThis polyclonal targets Histone H4
View all literature mentionsThis polyclonal targets H3K18ac
View all literature mentionsThis polyclonal targets Histone H1
View all literature mentionsThis polyclonal targets H3K9ac
View all literature mentionsThis monoclonal targets alpha-Tubulin
View all literature mentionsThis polyclonal targets Histone H3
View all literature mentionsThis polyclonal targets H3K56ac
View all literature mentionsThis monoclonal targets SIRT7 (C-3)
View all literature mentionsThis monoclonal targets SIRT4 (H-234)
View all literature mentionsThis monoclonal targets SirT6
View all literature mentionsThis monoclonal targets SirT3 (D22A3) Rabbit mAb
View all literature mentionsThis monoclonal targets SIRT5 (G-2)
View all literature mentionsThis monoclonal targets SirT2
View all literature mentionsThis monoclonal targets beta Actin
View all literature mentionsThis monoclonal targets Sirt1(Sir2)
View all literature mentionsMus musculus with name B6;129-Sirt1tm1Ygu/J from IMSR.
View all literature mentionsMus musculus with name STOCK Mir34atm1.2Aven/J from IMSR.
View all literature mentionsMus musculus with name B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn/J from IMSR.
View all literature mentions